Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter
about
Glucose-6-phosphatase deficiencyG-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasisLack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndromeThe SLC37 family of sugar-phosphate/phosphate exchangersGlycogen storage disease type I and G6Pase-β deficiency: etiology and therapyA potential new role for muscle in blood glucose homeostasisBone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functionsGlycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis FunctionSmall molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease.High-throughput screening based identification of small molecule antagonists of integrin CD11b/CD18 ligand binding.Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin.Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.Neutropenia in type Ib glycogen storage diseaseRecombinant AAV-directed gene therapy for type I glycogen storage diseases.Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.Animal models of human granulocyte diseases.The SLC37 family of phosphate-linked sugar phosphate antiporters.Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type IbGene therapy for type I glycogen storage diseasesGlucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice.Neutrophilia and elevated serum cytokines are implicated in glycogen storage disease type Ia.Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?B7-H4-deficient mice display augmented neutrophil-mediated innate immunity.Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice.Molecular mechanisms of metabolic reprogramming in proliferating cells: implications for T-cell-mediated immunity.Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.Identification of glucose-6-phosphate transporter as a key regulator functioning at the autophagy initiation step.Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E.Liver-directed gene therapy for murine glycogen storage disease type Ib.The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia.Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b.Pediatric inflammatory bowel disease: what children can teach adults.Maintenance of luminal NADPH in the endoplasmic reticulum promotes the survival of human neutrophil granulocytes.Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells.Deletion of the gene encoding the ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein (UGRP)/glucose-6-phosphatase catalytic subunit-beta results in lowered plasma cholesterol and elevated glucagon.
P2860
Q21202870-70BCDED9-6B87-4F5C-A608-FBB39DABC765Q24606712-790D7001-5AF5-4C12-9D5D-828C7E7C7EA9Q24613779-C9F73AD2-CED3-4919-B395-3A30D6F43C94Q26865636-3796F00E-1391-425D-B87E-5C32EAE96060Q28296663-B0316061-6A05-4BEB-85AC-2D250A319EEFQ28508734-B9BA4871-F1B6-4300-9507-AC7827F6C525Q28513160-5B169C58-5B81-4AFC-BEAF-2186582FA570Q28587708-8EE56417-2731-49FB-AC43-DAECE47F434EQ28592552-F71ADC32-1C35-4BDE-9DBE-7B92395FA790Q30658251-24059B1B-231F-4619-BDCD-0E22F2F22381Q33534982-5E86498B-A1E8-4577-AA0D-F50D58248E42Q34652348-9C636347-3F21-4A75-8FC1-CE01EB888634Q34654019-5CEBB350-2EAC-47C7-A944-7F0C10B27F2EQ34996563-58ED2D2B-4D8D-4D02-A268-094224AE2C2FQ35078590-BB4D8077-EF20-4E7C-8571-E10E438F2219Q35635511-FB243E48-99A8-46EA-8F2A-2BB6F80DD6FFQ36573814-DABA5775-92B0-4F88-898E-642B40D2A133Q36700318-ADC33E0D-FEFC-4D64-B23D-5A7DE1972669Q36713557-4A713B03-17F8-4BBF-8B2D-E669A8179895Q36789527-E34FF06B-7490-4B2C-A2D9-622CA5B6653CQ36828787-AA7C91DB-9523-4C4E-927F-285578F32E69Q36909624-30E2ADBE-B8B9-4C45-A03F-BDB36DBA6EF2Q36995948-CEBA679C-D448-48BE-B2BE-F4E174DA8CF6Q37109394-2DD56C40-FE04-46C4-895E-E238E37595F8Q37309846-A4CF3D15-6AFE-476E-8101-678D36A7F8FAQ37348313-6D218B2C-26D5-4C05-957B-61E6C1616DD6Q37387718-0B360BD1-A8C7-4A79-B5F6-E22E879CCB3EQ37415343-64C853ED-19D7-49FC-AC8E-3D1CC388ECBEQ37989980-821B7A63-AC66-46C1-95F4-D0CCBB6A351DQ38257397-446D8505-3DDF-4BAB-A566-1AD808694CE9Q38873899-A136C184-8C1B-4570-B59A-F1C208502D6AQ39128543-0443CF56-3C34-48E4-93CD-0BDD04D215FEQ41925391-92FEC2A4-9D75-4A38-BE1B-D0144067886CQ41986400-EEE9B7BE-E30C-432B-849A-4ED24B141F4FQ44586480-E0A7E70F-EE5F-4CA1-9C5D-5155BD36EA2EQ46485748-9385DC53-3258-4807-B827-A13C54B001C3Q46500039-0D3C8485-2AF0-427A-9637-C3BBA4C35D09Q46601399-80427554-1417-42BA-A47D-9F978CD6221AQ46759430-0A5CFFA6-7A86-45E5-9823-976C3CD2DBF6Q48403446-88A4135E-613B-4B3E-A1ED-FB42AEAB9C7B
P2860
Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter
description
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2003
@ast
im Oktober 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2003/10/01)
@sk
vědecký článek publikovaný v roce 2003
@cs
wetenschappelijk artikel (gepubliceerd op 2003/10/01)
@nl
наукова стаття, опублікована в жовтні 2003
@uk
مقالة علمية (نشرت في أكتوبر 2003)
@ar
name
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@ast
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@en
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@nl
type
label
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@ast
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@en
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@nl
prefLabel
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@ast
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@en
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@nl
P2093
P356
P1476
Impaired glucose homeostasis, ...... lucose-6-phosphate transporter
@en
P2093
Baochuan Lin
Brian C. Mansfield
Chi-Jiunn Pan
Eric J. Lee
Heiner Westphal
Janice Yang Chou
Jeng-Jer Shieh
Jerrold M. Ward
Ji-Liang Gao
Li-Yuan Chen
P304
P356
10.1093/HMG/DDG263
P577
2003-10-01T00:00:00Z